Xiao-Ou Shu, MD of @VUMChealth explains that in a recent study, men have a higher mortality rate than women due to multiple contributors. #breastcancer
___________
Men may be more likely than women to die after being diagnosed with breast cancer, particularly during the first 5 years after diagnosis, a new study suggests.
In the study, the 5-year
AVEO Oncology, a subsidiary of LG Chem, has announced the acceptance of its Phase 3 TiNivo-2 trial for a Proffered Paper oral presentation at the…
Dr. Nathalie M. Johnson, MD, discusses the importance of adopting ctDNA testing in breast cancer management. Find out how it can benefit patients with high-risk…
Exciting news in endometrial cancer treatment: FDA approves dostarlimab-gxly for broader patient population. Learn about the clinical trial and its positive results.
Discover the problem of underutilization of genetic testing in cancer. Find out how it can lead to missed opportunities for early intervention.
Introduction On August 2, 2024, the FDA granted accelerated approval to afamitresgene autoleucel (TECELRA) for treating adults with unresectable or metastatic synovial sarcoma. This approval…
Exciting news in endometrial cancer treatment: FDA approves dostarlimab-gxly for broader patient population. Learn about the clinical trial and its positive results.
Discover the potential of ctDNA monitoring in revolutionizing cancer treatment. Genetic testing advancements offer new insights into cancer recurrence detection.
Learn about the latest advancements in small cell lung cancer treatment and discover effective treatment options for this aggressive form of cancer.
Learn about ctDNA testing for cancer markers and its potential impact on treatment decisions. Explore the insights shared by Dr. Barry Rosen in this informative…
We are excited to extend a special discounted invitation for the next 9 hematologists to register for the upcoming AML-ALL Meeting in La Jolla, CA…
